Follow The Filings

CNTX Context Therapeutics

Context Therapeutics earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -0.11 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 3.01
SCHEDULE 13G —
8-K 5.03,5.07,9.01
8-K 7.01,8.01,9.01
8-K 1.01,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 8.01
DEF 14A
DEFA14A
8-K 7.01,8.01,9.01
10-K
8-K 7.01,8.01,9.01
8-K 5.03,8.01,9.01
8-K 8.01
SCHEDULE 13G/A —

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jun 24, 2026 (5 forms)

5 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf